These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22484396)

  • 21. Evaluation of high-resolution mass spectrometry for urine toxicology screening in a pain management setting.
    Crews BO; Pesce AJ; West R; Nguyen H; Fitzgerald RL
    J Anal Toxicol; 2012; 36(9):601-7. PubMed ID: 22995480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of oral fluid in compliance monitoring of opioid medications.
    Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
    Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines.
    Way BA; Walton KG; Koenig JW; Eveland BJ; Scott MG
    Clin Chim Acta; 1998 Mar; 271(1):1-9. PubMed ID: 9564553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid.
    Allen KR; Azad R; Field HP; Blake DK
    Ann Clin Biochem; 2005 Jul; 42(Pt 4):277-84. PubMed ID: 15989728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
    Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
    J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous analysis of thirty-five benzodiazepines in urine using liquid chromatography-mass spectrometry-time of flight.
    ElSohly MA; Gul W; Avula B; Murphy TP; Khan IA
    J Anal Toxicol; 2008 Oct; 32(8):547-61. PubMed ID: 19007503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic Pain.
    Snyder ML; Fantz CR; Melanson S
    Pain Physician; 2017 Feb; 20(2S):SE1-SE9. PubMed ID: 28226337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analyses of benzodiazepines and their metabolites in various biological matrices by LC-MS(/MS).
    Nakamura M
    Biomed Chromatogr; 2011 Dec; 25(12):1283-307. PubMed ID: 21400551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay.
    Glover SJ; Allen KR
    Ann Clin Biochem; 2010 Mar; 47(Pt 2):111-7. PubMed ID: 19969595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Two Immunoassay Screening Methods and a LC-MS/MS in Detecting Traditional and Designer Benzodiazepines in Urine.
    Rossi B; Freni F; Vignali C; Stramesi C; Collo G; Carelli C; Moretti M; Galatone D; Morini L
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine drug screening: a valuable office procedure.
    Standridge JB; Adams SM; Zotos AP
    Am Fam Physician; 2010 Mar; 81(5):635-40. PubMed ID: 20187600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays.
    Wood L; Ducroq DH; Fraser HL; Gillingwater S; Evans C; Pickett AJ; Rees DW; John R; Turkes A
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):380-8. PubMed ID: 18583623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoassay in healthcare testing applications.
    DePriest AZ; Black DL; Robert TA
    J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method.
    McCann SJ; Gillingwater S; Keevil BG; Cooper DP; Morris MR
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):161-5. PubMed ID: 12662404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micellar electrokinetic capillary chromatography of benzodiazepines in human urine.
    Schafroth M; Thormann W; Allemann D
    Electrophoresis; 1994 Jan; 15(1):72-8. PubMed ID: 8143683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Performance of Triagetrade mark for Benzodiazepines: Urine Analysis of the Dose of Therapeutic Cases.
    Kurisaki E; Hayashida M; Nihira M; Ohno Y; Mashiko H; Okano T; Niwa SI; Hiraiwa K
    J Anal Toxicol; 2005; 29(6):539-543. PubMed ID: 16297284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine Drug Tests: Ordering and Interpreting Results.
    Kale N
    Am Fam Physician; 2019 Jan; 99(1):33-39. PubMed ID: 30600984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future applications of high-resolution MS to meet the demands for pain management drug testing.
    Crews BO
    Bioanalysis; 2014; 6(21):2839-53. PubMed ID: 25486231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of benzodiazepines in urine via benzophenone derivatives using liquid chromatography-tandem mass spectrometry.
    Roškar R; Sollner Dolenc M
    Arh Hig Rada Toksikol; 2010 Dec; 61(4):381-8. PubMed ID: 21183429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.